MGX
Metagenomi (MGX)
$54
About Metagenomi (MGX)
Metagenomi Therapeutics, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene editing toolbox, therapeutic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA.
Details
Daily high
$1.55
Daily low
$1.39
Price at open
$1.46
52 Week High
$3.95
52 Week Low
$1.23
Market cap
57.8M
Dividend yield
0.00%
Volume
443,902
Avg. volume
287,781
P/E ratio
-.65
Metagenomi News
Details
Daily high
$1.55
Daily low
$1.39
Price at open
$1.46
52 Week High
$3.95
52 Week Low
$1.23
Market cap
57.8M
Dividend yield
0.00%
Volume
443,902
Avg. volume
287,781
P/E ratio
-.65